Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.750
-0.190 (-6.46%)
At close: Jun 26, 2026, 4:00 PM EDT
2.500
-0.250 (-9.09%)
After-hours: Jun 26, 2026, 8:00 PM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.41 million as of June 26, 2026. Its market cap has decreased by -63.99% in one year.
Market Cap
6.41M
Enterprise Value
-2.59M
1-Year Change
-63.99%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.41M, a decrease of -65.31%. That is a compound annual growth rate of -5.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 6.41M | -73.97% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curanex Pharmaceuticals | 7.52M |
| Creative Medical Technology Holdings | 7.43M |
| Imunon | 7.35M |
| NuCana | 7.03M |
| Xenetic Biosciences | 6.64M |
| Aptorum Group | 6.49M |
| Acurx Pharmaceuticals | 6.37M |
| Silo Pharma | 6.35M |